SENORES PHARMACEUTICALS L (SENORES) — Net Asset Quality Index
SENORES PHARMACEUTICALS L (SENORES) has a Net Asset Quality Index of 64.8% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Rs12.88 Billion minus total liabilities of Rs4.54 Billion yields net assets of Rs8.34 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check financial resilience of SENORES PHARMACEUTICALS L to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
SENORES PHARMACEUTICALS L Net Asset Quality Index Over Time (2022–2025)
This chart shows how SENORES PHARMACEUTICALS L's Net Asset Quality Index has evolved across 4 annual periods from 2022 to 2025. As of September 2025, the index stands at 64.8%, representing net assets of Rs8.34 Billion against total assets of Rs12.88 Billion INR. See working capital position of SENORES PHARMACEUTICALS L to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for SENORES PHARMACEUTICALS L (2022–2025)
The table below presents the year-by-year Net Asset Quality Index for SENORES PHARMACEUTICALS L from 2022 to 2025, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see SENORES market cap.
| Year | Quality Index | Net Assets (INR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 65.2% | Rs94.96 Million | Rs145.66 Million | Rs50.70 Million | ▲ +27.9 pp |
| 2024 | 37.3% | Rs2.32 Billion | Rs6.22 Billion | Rs3.90 Billion | ▲ +2.5 pp |
| 2023 | 34.7% | Rs454.99 Million | Rs1.31 Billion | Rs855.54 Million | ▼ -27.1 pp |
| 2022 | 61.9% | Rs365.90 Million | Rs591.52 Million | Rs225.62 Million | — |